Friedrich Reinhard E, Hagel Christian
Department of Oral and Craniomaxillofacial Surgery, Eppendorf University Hospital, University of Hamburg, Hamburg, Germany.
Institute of Neuropathology, Eppendorf University Hospital, University of Hamburg, Hamburg, Germany.
Cancer Diagn Progn. 2025 Mar 3;5(2):244-254. doi: 10.21873/cdp.10436. eCollection 2025 Mar-Apr.
BACKGROUND/AIM: Neurofibromatosis type 1 (NF1) is an autosomal dominant hereditary tumor predisposition syndrome. In approximately 30% of cases, plexiform neurofibromas (PNFs) are identified, which are precursor lesions for malignant peripheral nerve sheath tumors (MPNSTs). MPNST is a major cause of the reduced life expectancy of NF1 patients.
The patient, a two-year-old at the time of surgical treatment, had been diagnosed with an orbital nerve sheath tumor causing lid swelling and ptosis since birth. The tumor showed disproportionately rapid growth, leading to increasing functional (mechanical) restrictions in lid elevation. Surgical exploration of the orbit indicated a PNF with areas of a MPNST. Two months later, a new biopsy confirmed the MPNST. The tumor was treated with multimodal chemotherapy. After completion of chemotherapy, orbital exenteration was performed. The tissue specimens only comprised tissue of a benign PNF. However, within six months, the patient developed an intracranial recurrence and died from a rapidly growing intracerebral tumor fraction, which histologically proved to be a MPNST.
Orbital PNF is a rare and characteristic manifestation of facial NF1. Typically, tumors in this localization are associated with severe functional disabilities and aesthetic disfigurement, resulting from invasive tumor growth and skeletal deformities. Histological classification of the tumors may be challenging due to varying histological differentiation in different tumor locations. Thus, early diagnosis with representative tumor sampling and complete histological work-up of the specimen together with multimodal therapy are essential prerequisites to overcome the poor prognosis of these tumors.
背景/目的:1型神经纤维瘤病(NF1)是一种常染色体显性遗传性肿瘤易感综合征。在大约30%的病例中可发现丛状神经纤维瘤(PNF),其为恶性外周神经鞘瘤(MPNST)的前驱病变。MPNST是NF1患者预期寿命缩短的主要原因。
该患者在接受手术治疗时为两岁,自出生起就被诊断患有眼眶神经鞘瘤,导致眼睑肿胀和上睑下垂。肿瘤生长异常迅速,导致上睑抬高的功能(机械性)受限日益加重。眼眶手术探查显示为伴有MPNST区域的PNF。两个月后,再次活检确诊为MPNST。对肿瘤进行了多模式化疗。化疗结束后,进行了眼眶内容物剜除术。组织标本仅包含良性PNF组织。然而,在六个月内,患者出现颅内复发,并死于快速生长的脑内肿瘤成分,组织学证实为MPNST。
眼眶PNF是面部NF1一种罕见且具有特征性的表现。通常,该部位的肿瘤会因肿瘤侵袭性生长和骨骼畸形而导致严重的功能障碍和美学缺陷。由于不同肿瘤部位的组织学分化不同,肿瘤的组织学分类可能具有挑战性。因此,通过代表性肿瘤取样进行早期诊断、对标本进行完整的组织学检查以及多模式治疗是克服这些肿瘤预后不良的必要前提。